Emmanuel J Favaloro/LinkedIn
Dec 16, 2025, 13:00
ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn:
“The ScholarGPS database has been updated. Honored to be ranked No. 1 in the World in lifetime category for the field of Hemostasis; 4th in the world for both Thrombosis and von Willebrand disease. Take a look to see if you are on the list.”
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
-
Dec 16, 2025, 23:14Shrinidhi Nathany: MRD in AML – From a Test to a Treatment Decision
-
Dec 16, 2025, 23:04Jim Hoffman: Timely Extracorporeal NET Removal Therapy Should Be Tried on High-Risk Patients
-
Dec 16, 2025, 22:16Wolfgang Miesbach – Targeting VEGF to Stop GI Bleeding: Systemic Bevacizumab
-
Dec 16, 2025, 17:14Piotr Czempik Honored for His Work on Cost Reduction in Blood Transfusions